• Home
  • MyECTS
  • Become a member
  • Contact us

Ectsoc

Ecstoc.org

MENUMENU
  • About
    • Mission & Vision
    • Governance & Transparency
    • Board of Directors
    • Annual General Meeting
    • Committees and Action Groups
      • Executive Committee
      • Communications Committee
      • Community Engagement Committee
      • ECTS Academy
      • Education Committee
      • Clinical Science Committee
      • Research Committee
      • Scientific Programme Committee 2025
    • ECTS Team
    • Membership
      • Individual Membership
      • Corporate Supporters
      • Join us
      • Affiliated Societies
  • ECTS 2025
  • Events
    • Upcoming Congresses
    • Past Congress
    • ECTS Academy Charity Event
    • ICCBH
    • Events
  • Grants & Awards
  • Education
    • PhD Training Course
    • Clinical Training Course in Metabolic Bone Diseases
    • Rare Bone Diseases Webinars
    • Education Resource Center
    • Bone Muscle & Beyond Webinars
    • ECTS-Mellanby Training Course
    • Calendar ECTS Educational Events
  • ECTS Academy
    • About the ECTS Academy
    • ECTS Academy – Members
    • Call for Applications - Basic Scientists
    • Call for Applications - Clinicians
    • ECTS Academy Activities
      • NI Conference Program
      • ECTS Academy Webinar Series
      • ECTS Academy Mentoring Options
      • ECTS Academy Charity Run
    • Visit the ECTS Academy website
  • News
    • ECTS Newsletter
    • News
    • Press Release
    • Image Library
    • Video Library
    • Job Advertisements
You are here: Home / Boards / Erik Fink Eriksen

Mar 15 2016

Erik Fink Eriksen

Erik Fink Eriksen is a Professor of Endocrinology at the University of Oslo. With 22 years of clinical medical and research experience in Internal medicine and Endocrinology, in particular calcium metabolic- and osteoporosis research. He was a consultant for several pharmaceutical companies (Procter & Gamble, Rhone Poulenc Rorer, Novo-Nordisk, Glaxo–Smith Kline, Merck) during that period. Over 6 years of experience as manager in the pharmaceutical industry, where he have taken two successful osteoporosis drugs (For(s)teo and Aclasta/Reclast) through clinical development, approval by regulatory authorities and global launch. Extensive experience in basic and clinical research within calcium metabolism and osteoporosis (>250 publications). My goal is to provide new solutions to unmet medical needs and expand our general knowledge in relation to musculoskeletal diseases.

Specialties: Clinical drug development, conduct and development of clinical trials, basic cellular and molecular research methodology, medical-marketing interactions, extensive clinical medical experience within internal medicine and endocrinology.

Copyright 2016 ECTS - Disclaimer - Cookies Policy - Privacy Policy - Privacy Centre - Terms of use - Contact us